WGXC-90.7 FM
Taconic announces job cuts
Jan 14, 2011 1:19 pm
[caption id="" align="alignleft" width="200" caption="Taconic Farm in Germantown. Photo supplied by company."]
[/caption]Taconic, the local commercial supplier of transgenic, inbred, outbred, and hybrid mice and rats, as well as a host of varied laboratory services throughout the United States and in Europe, has announced that it plans to reduce its global workforce of approximately 1,000 employees by 49 positions, with 30 of those cuts coming from its Germantown facilities. Taconic is reorganizing its management structure for its companies in Germany, New Jersey and Denmark, forcing a company-wide need to consolidate some operations to provide better service to our customers. Corporate officials are saying, however, that they "will continue full operations at its sites in Germantown [Taconic Farms] and the Albany capital district" and maintain headquarters in Hudson, even with the cuts. "This restructuring is being implemented in response to issues created largely by the economic climate of the last three years and the negative impact those issues have had on pharmaceutical drug development," the company noted in a recent press release. "Pharmaceutical companies have closed an unprecedented number of research and development sites and reduced their numbers of employees by tens of thousands in the last 18 to 24 months. “Taconic’s long-term technology-based strategy is sound and we expect pharmaceutical companies to return to increased levels of drug discovery activity now that mergers and downsizing in the pharmaceutical sector have leveled off,” stated Todd F. Little, president and CEO. “Taconic has long-held value that our employees are essential to our success. We are supporting each departing employee in every way possible through their transition to alternate employment.”
[/caption]Taconic, the local commercial supplier of transgenic, inbred, outbred, and hybrid mice and rats, as well as a host of varied laboratory services throughout the United States and in Europe, has announced that it plans to reduce its global workforce of approximately 1,000 employees by 49 positions, with 30 of those cuts coming from its Germantown facilities. Taconic is reorganizing its management structure for its companies in Germany, New Jersey and Denmark, forcing a company-wide need to consolidate some operations to provide better service to our customers. Corporate officials are saying, however, that they "will continue full operations at its sites in Germantown [Taconic Farms] and the Albany capital district" and maintain headquarters in Hudson, even with the cuts. "This restructuring is being implemented in response to issues created largely by the economic climate of the last three years and the negative impact those issues have had on pharmaceutical drug development," the company noted in a recent press release. "Pharmaceutical companies have closed an unprecedented number of research and development sites and reduced their numbers of employees by tens of thousands in the last 18 to 24 months. “Taconic’s long-term technology-based strategy is sound and we expect pharmaceutical companies to return to increased levels of drug discovery activity now that mergers and downsizing in the pharmaceutical sector have leveled off,” stated Todd F. Little, president and CEO. “Taconic has long-held value that our employees are essential to our success. We are supporting each departing employee in every way possible through their transition to alternate employment.”